Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Auris, Nasus, Larynx|July 13, 2025
Course of a sudden sensorineural hearing loss case diagnosed as intra-labyrinthine hemorrhage with MRI in the early phaseKenta Ide, Makoto Hosoya, Takanori Nishiyama, et al.
Plos One|November 1, 2018
Effect of single caffeine intake on neuropsychological functions in healthy volunteers: A double-blind placebo-controlled studyYuki Konishi, Hikaru Hori, Kenta Ide, et al.
Neuropsychopharmacology Reports|March 2, 2026
Eight-Year Progression of Clinical Practice Implementation Following Guideline Training in the EGUIDE ProjectKenta Ide, Kazuhiko Yamamuro, Hisashi Yamada, et al.
PCN Reports : Psychiatry and Clinical Neurosciences|December 25, 2025
Clinical behavior toward outpatients with major depressive disorder based on guideline education for psychiatristsHirotaka Yamagata, Kenta Ide, Shinichiro Ochi, et al.
Neuropsychopharmacology Reports|July 14, 2026
Association Between Participant Satisfaction and Self-Reported Clinical Practice Behaviors in a Nationwide Guideline Education ProgramKazuhiko Yamamuro, Kenta Ide, Yusuke Arai, et al.
Asian Journal of Psychiatry|January 20, 2022
The characteristics of patients receiving psychotropic pro re nata medication at discharge for the treatment of schizophrenia and major depressive disorder: A nationwide survey from the EGUIDE projectKayo Ichihashi, Yoshitaka Kyou, Naomi Hasegawa, et al.
Neuropsychopharmacology Reports|November 17, 2022
Development of an individual fitness score (IFS) based on the depression treatment guidelines of in the Japanese Society of Mood DisordersKentaro Fukumoto, Fumitoshi Kodaka, Naomi Hasegawa, et al.
Annals of General Psychiatry|December 25, 2022
The characteristics of discharge prescriptions including pro re nata psychotropic medications for patients with schizophrenia and major depressive disorder from the survey of the "Effectiveness of guidelines for dissemination and education in psychiatric treatment (EGUIDE)" projectYoshitaka Kyou, Norio Yasui-Furukori, Naomi Hasegawa, et al.
Neuropsychopharmacology Reports|October 18, 2022
Development of individual fitness score for conformity of prescriptions to the "Guidelines For Pharmacological Therapy of Schizophrenia"Ken Inada, Kentaro Fukumoto, Naomi Hasegawa, et al.
Psychiatry and Clinical Neurosciences|September 9, 2023
Effect of education regarding treatment guidelines for schizophrenia and depression on the treatment behavior of psychiatrists: A multicenter studyNaomi Hasegawa, Yuka Yasuda, Norio Yasui-Furukori, et al.
Pageof 1